Crossmark

MAP3K7 is recurrently deleted in pediatric T-lymphoblastic leukemia and affects cell proliferation independently of NF-κB

Crossref DOI link: https://doi.org/10.1186/s12885-018-4525-0

Published Online: 2018-06-18

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cordas dos Santos, David M.

Eilers, Juliane

Sosa Vizcaino, Alfonso

Orlova, Elena

Zimmermann, Martin

Stanulla, Martin

Schrappe, Martin

Börner, Kathleen

Grimm, Dirk

Muckenthaler, Martina U.

Kulozik, Andreas E.

Kunz, Joachim B. https://orcid.org/0000-0003-0946-3928
Funding

Funding for this research was provided by:

German Consortium for Translational Cancer Research

Tour der Hoffnung

Manfred Lautenschläger-Stiftung

European Commission, ERA-Net on Translational Cancer Research, TRANSCALL

Cluster of Excellence CellNetworks

Deutsches Zentrum für Infektionsforschung

Heidelberg Research Center for Molecular Medicine

The Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology
License Information

Text and Data Mining valid from 2018-06-18
More Information

Article History

Received: 25 September 2017

Accepted: 18 May 2018

First Online: 18 June 2018

Ethics approval and consent to participate

: This study was approved by the institutional review boards of the Hannover Medical School and University of Schleswig-Holstein. Informed consent was obtained in accordance with the declaration of Helsinki.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.